PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, 9033
N. diseases: 124; N. variants: 10
Source: ALL
Disease | Type | Disease Class | Semantic Type | N. genes d | N. SNPs d | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
disease | Mental or Behavioral Dysfunction | 10 | 0.040 | None | 1.000 | 4 | 2017 | 2019 | |||||||
|
phenotype | Mental or Behavioral Dysfunction | 70 | 6 | 0.030 | None | 0.667 | 3 | 2011 | 2018 | ||||||
|
phenotype | Laboratory Procedure | 58 | 306 | 0.100 | None | 1.000 | 2 | 1 | 2012 | 2013 | |||||
|
phenotype | Sign or Symptom | 4 | 0.020 | None | 1.000 | 2 | 2009 | 2019 | |||||||
|
phenotype | Mental or Behavioral Dysfunction | 40 | 11 | 0.010 | None | 1.000 | 1 | 2018 | 2018 | ||||||
|
phenotype | Sign or Symptom | 6 | 0.010 | None | 1.000 | 1 | 2018 | 2018 | |||||||
|
phenotype | Laboratory Procedure | 223 | 371 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||
|
phenotype | Laboratory Procedure | 563 | 1418 | 0.100 | None | 1.000 | 1 | 2 | 2012 | 2012 | |||||
|
disease | Anatomical Abnormality | 13 | 2 | 0.010 | None | 1.000 | 1 | 2019 | 2019 | ||||||
|
disease | Disease or Syndrome | 19 | 0.010 | None | 1.000 | 1 | 1998 | 1998 | |||||||
|
phenotype | Laboratory Procedure | 89 | 111 | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | |||||
|
phenotype | Laboratory Procedure | 593 | 988 | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||
|
phenotype | Clinical Attribute | 507 | 1037 | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||
|
phenotype | Finding | 89 | 111 | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | |||||
|
phenotype | Laboratory Procedure | 433 | 3282 | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | |||||
|
disease | Neoplastic Process | 860 | 154 | 0.010 | None | 1.000 | 1 | 2019 | 2019 | ||||||
|
disease | Mental or Behavioral Dysfunction | 14 | 3 | 0.010 | None | < 0.001 | 1 | 2018 | 2018 | ||||||
|
phenotype | Clinical Attribute | 843 | 1931 | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||
|
phenotype | Neoplastic Process | 6626 | 169 | 0.010 | None | 1.000 | 1 | 2017 | 2017 | ||||||
|
group | Laboratory Procedure | 50 | 116 | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | |||||
|
phenotype | Laboratory or Test Result | 593 | 988 | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||
|
disease | Disease or Syndrome | 2 | 0.010 | None | 1.000 | 1 | 2017 | 2017 | |||||||
|
disease | Mental or Behavioral Dysfunction | 3 | 0.010 | None | 1.000 | 1 | 2019 | 2019 | |||||||
|
disease | Neoplastic Process | 3669 | 502 | 0.010 | None | 1.000 | 1 | 2018 | 2018 | ||||||
|
disease | Behavior and Behavior Mechanisms | Mental or Behavioral Dysfunction | 1478 | 271 | 0.090 | None | 0.889 | 9 | 2017 | 2020 |